Christian Gisselbrecht Selected Research

Christian Gisselbrecht Research Topics

Disease

34	Lymphoma (Lymphomas) 05/2019 - 02/2002
26	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2002
20	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 02/2002
15	Neoplasms (Cancer) 05/2022 - 06/2003
9	Nausea 07/2021 - 01/2013
9	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020 - 03/2002
8	Multiple Myeloma 11/2021 - 03/2015
8	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 10/2007
8	Anemia 08/2021 - 08/2009
8	Thrombocytopenia (Thrombopenia) 01/2021 - 08/2009
8	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 06/2003
7	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 11/2012
7	Disease Progression 01/2021 - 01/2008
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019 - 11/2004
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2013 - 02/2002
6	Diarrhea 08/2021 - 01/2016
6	Fatigue 08/2021 - 03/2013
6	Neutropenia 01/2021 - 08/2009
4	Pain (Aches) 08/2021 - 07/2011
4	Fever (Fevers) 08/2021 - 03/2015
4	Infections 01/2021 - 09/2006
4	Vomiting 11/2019 - 01/2013
3	Arthralgia (Joint Pain) 08/2021 - 01/2020
3	Headache (Headaches) 08/2021 - 11/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2016
3	Asthenia 01/2020 - 08/2009
3	Lymphopenia (Lymphocytopenia) 01/2018 - 03/2013
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2015 - 04/2005
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2009 - 05/2006
2	Back Pain (Backache) 08/2021 - 01/2019
2	Cough 08/2021 - 01/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2008
2	Constipation 01/2020 - 01/2019
2	Edema (Dropsy) 01/2020 - 03/2015
2	Residual Neoplasm 01/2020 - 01/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2020
2	Myalgia 01/2020 - 03/2013
2	Drug-Related Side Effects and Adverse Reactions 11/2019 - 01/2016
2	Febrile Neutropenia 11/2019 - 01/2016
2	Pneumonia (Pneumonitis) 01/2018 - 03/2015
2	Pathologic Complete Response 12/2014 - 06/2006
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2011 - 02/2009

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 01/2015 - 01/2002
13	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2002
13	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2002
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2002
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2002
11	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 08/2010
9	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 08/2010
7	Monoclonal AntibodiesIBA 12/2021 - 01/2002
6	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 09/2010
5	Lenalidomide (CC 5013)FDA Link 12/2021 - 03/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2003
4	Bortezomib (Velcade)FDA Link 01/2018 - 10/2009
3	Anaplastic Lymphoma KinaseIBA 01/2019 - 11/2012
3	Brentuximab VedotinIBA 01/2018 - 04/2015
3	Melphalan (Alkeran)FDA LinkGeneric 12/2014 - 01/2005
3	Cisplatin (Platino)FDA LinkGeneric 11/2014 - 11/2011
3	Ifosfamide FDA LinkGeneric 01/2012 - 09/2010
2	pomalidomideIBA 11/2021 - 03/2015
2	Proteasome InhibitorsIBA 01/2021 - 01/2018
2	AntigensIBA 01/2021 - 01/2002
2	Chimeric Antigen ReceptorsIBA 10/2020 - 01/2020
2	fms-Like Tyrosine Kinase 3IBA 01/2020 - 11/2019
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 03/2013
2	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2019 - 01/2019
2	PanobinostatIBA 07/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 11/2004
2	Immunoconjugates (Immunoconjugate)IBA 04/2015 - 04/2010
2	TOR Serine-Threonine KinasesIBA 01/2015 - 08/2009
2	Inotuzumab OzogamicinIBA 01/2015 - 04/2010
2	temsirolimus FDA Link 01/2015 - 08/2009
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 04/2011
2	Yttrium-90IBA 12/2014 - 04/2011
2	pixantrone (BBR 2778)IBA 01/2013 - 08/2003
2	IceIBA 05/2012 - 01/2012
2	Carboplatin (JM8)FDA LinkGeneric 01/2012 - 11/2011
2	Methotrexate (Mexate)FDA LinkGeneric 09/2010 - 05/2008
2	Bleomycin (Blenoxane)FDA LinkGeneric 06/2006 - 12/2003
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2005 - 08/2003
1	Antigen Receptors (Antigen Receptor)IBA 01/2023
1	tafasitamabIBA 12/2021
1	CD19 AntigensIBA 12/2021
1	isatuximabIBA 11/2021

Therapy/Procedure

52	Therapeutics 05/2022 - 02/2002
35	Stem Cell Transplantation 01/2021 - 02/2002
34	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
12	Transplantation 05/2019 - 01/2003
6	Autologous Transplantation 11/2020 - 10/2007
4	Radioimmunotherapy 01/2012 - 01/2009
3	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 03/2007
3	Salvage Therapy 11/2011 - 12/2008
3	Chemoradiotherapy 03/2007 - 04/2005
2	Intravenous Infusions 01/2021 - 03/2013
2	Immunotherapy 01/2020 - 01/2012
2	Consolidation Chemotherapy 11/2019 - 06/2006
2	Cell Transplantation 05/2019 - 11/2017
2	BEAM regimen 12/2014 - 04/2011
2	VAP-cyclo protocol 09/2006 - 01/2002
2	Aftercare (After-Treatment) 09/2006 - 02/2004